Cerebrospinal Fluid Biomarkers in Neurosarcoidosis: Evaluating the IL-2 and IL-6 Pathways (P1-8.005)
To assess levels of cerebrospinal fluid (CSF) cytokines associated with interleukins IL-2 and IL-6 pathways in patients with neurosarcoidosis (NS) and compare them with systemic sarcoidosis without neurological involvement (SS), inflammatory, and non-inflammatory controls (NIC).
Authors
- Samuel J. Pleasure (ORCID: https://orcid.org/0000-0001-8599-1613)
- Paula Barreras (ORCID: https://orcid.org/0000-0002-3837-7183)
- Carlos Pardo‐Villamizar
- Kathryn C. Fitzgerald (ORCID: https://orcid.org/0000-0003-3137-0322)
- Michael L. Wilson (ORCID: https://orcid.org/0000-0003-3073-4518)
- Greer Waldrop (ORCID: https://orcid.org/0000-0001-6408-2330)
- Susana Dominguez Penuela
- Jeffrey Marc Gelfand (ORCID: https://orcid.org/0000-0002-5121-3319)
- H. Benjamin Larman (ORCID: https://orcid.org/0000-0001-7863-196X)
- Barney J. Stern (ORCID: https://orcid.org/0000-0001-8745-538X)
- Maria Reyes‐Mantilla (ORCID: https://orcid.org/0000-0003-2717-3545)
- Evan Johnson
- David Acero-Garces
Institutions
- Cedars-Sinai Medical Center (US)
- Johns Hopkins University (US)
- University of California, San Francisco (US)
- Johns Hopkins Medicine (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211908
- Primary Topic
- Sarcoidosis and Beryllium Toxicity Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00